Lake County Nursing And Rehabilitation Center | |
5025 Mccook Ave, East Chicago, Indiana 46312 | |
(219) 397-0380 | |
Name | Lake County Nursing And Rehabilitation Center |
---|---|
Location | 5025 Mccook Ave, East Chicago, Indiana |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 117 |
Occupancy Rate | 51.2% |
Medicare ID (CCN) | 155653 |
Legal Business Name | Major Hospital |
Ownership Type | For Profit - Corporation |
NPI Number | 1255457826 |
Organization Name | MAJOR HOSPITAL |
Address | 5025 Mccook Ave, East Chicago, IN 46312 |
Phone Number | 219-397-0380 |
News Archive
Cannabis Science Inc., a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials. Based on extensive studies, the Company has decided to contract with a group based in Colorado to handle the Company's FDA filings.
More than a decade ago, radiation oncologists noticed a nifty phenomenon: Sometimes radiation used locally against a tumor could excite the immune system to attack cancer systemically throughout the body.
Cell Press is delighted to announce the launch of its new iPhone app - Cell Alerts, available to download for free at www.cell.com/iphone or http://bit.ly/fw9pbx.
Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Cannabis Science Inc., a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials. Based on extensive studies, the Company has decided to contract with a group based in Colorado to handle the Company's FDA filings.
More than a decade ago, radiation oncologists noticed a nifty phenomenon: Sometimes radiation used locally against a tumor could excite the immune system to attack cancer systemically throughout the body.
Cell Press is delighted to announce the launch of its new iPhone app - Cell Alerts, available to download for free at www.cell.com/iphone or http://bit.ly/fw9pbx.
Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 3 |
Total Amount of Fines in Dollars | $26985 |
Number of Payment Denials | 1 |
Total Number of Penalties | 4 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 26.01 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.86 | 5.51 |